Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 9 de 9
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Neurosci Lett ; 664: 160-166, 2018 01 18.
Article de Anglais | MEDLINE | ID: mdl-29133177

RÉSUMÉ

Traumatic brain injury (TBI) is a serious public health concern, especially injuries from repetitive insults. The main objective of this study was to immunocytochemically examine morphological alterations in astrocytes and microglia in the hippocampus 48h following a single blast versus multiple blasts in adult C57BL/6 mice. The effects of ketamine and xylazine (KX), two common anesthetic agents used in TBI research, were also evaluated due to the confounding effect of anesthetics on injury outcome. Results showed a significant increase in hypertrophic microglia that was limited to the outer molecular layer of the dentate gyrus, but only in the absence of KX. Although the presence or absence of KX had no effect on astrocytes following a single blast, a significant decrease in astrocytic immunoreactivity was observed in the stratum lacunosum moleculare following multiple blasts in the absence of KX. The morphological changes in astrocytes and microglia reported in this study reveal region-specific differences in the absence of KX that could have significant implications for our interpretation of glial alterations in animal models of injury.


Sujet(s)
Anesthésiques/pharmacologie , Lésions traumatiques de l'encéphale/anatomopathologie , Hippocampe/anatomopathologie , Kétamine/pharmacologie , Xylazine/pharmacologie , Animaux , Astrocytes/effets des médicaments et des substances chimiques , Astrocytes/anatomopathologie , Traumatismes par explosion/anatomopathologie , Modèles animaux de maladie humaine , Hippocampe/effets des médicaments et des substances chimiques , Mâle , Souris , Souris de lignée C57BL , Microglie/effets des médicaments et des substances chimiques , Microglie/anatomopathologie
2.
Front Physiol ; 7: 287, 2016.
Article de Anglais | MEDLINE | ID: mdl-27462275

RÉSUMÉ

Most tissues in the body are under mechanical tension, and while enzymes mediate many cellular and extracellular processes, the effects of mechanical forces on enzyme reactions in the native extracellular matrix (ECM) are not fully understood. We hypothesized that physiological levels of mechanical forces are capable of modifying the activity of collagenase, a key remodeling enzyme of the ECM. To test this, lung tissue Young's modulus and a nonlinearity index characterizing the shape of the stress-strain curve were measured in the presence of bacterial collagenase under static uniaxial strain of 0, 20, 40, and 80%, as well as during cyclic mechanical loading with strain amplitudes of ±10 or ±20% superimposed on 40% static strain, and frequencies of 0.1 or 1 Hz. Confocal and electron microscopy was used to determine and quantify changes in ECM structure. Generally, mechanical loading increased the effects of enzyme activity characterized by an irreversible decline in stiffness and tissue deterioration seen on both confocal and electron microscopic images. However, a static strain of 20% provided protection against digestion compared to both higher and lower strains. The decline in stiffness during digestion positively correlated with the increase in equivalent alveolar diameters and negatively correlated with the nonlinearity index. These results suggest that the decline in stiffness results from rupture of collagen followed by load transfer and subsequent rupture of alveolar walls. This study may provide new understanding of the role of collagen degradation in general tissue remodeling and disease progression.

3.
Development ; 143(4): 703-14, 2016 Feb 15.
Article de Anglais | MEDLINE | ID: mdl-26755701

RÉSUMÉ

The sea urchin larval skeleton offers a simple model for formation of developmental patterns. The calcium carbonate skeleton is secreted by primary mesenchyme cells (PMCs) in response to largely unknown patterning cues expressed by the ectoderm. To discover novel ectodermal cues, we performed an unbiased RNA-Seq-based screen and functionally tested candidates; we thereby identified several novel skeletal patterning cues. Among these, we show that SLC26a2/7 is a ventrally expressed sulfate transporter that promotes a ventral accumulation of sulfated proteoglycans, which is required for ventral PMC positioning and skeletal patterning. We show that the effects of SLC perturbation are mimicked by manipulation of either external sulfate levels or proteoglycan sulfation. These results identify novel skeletal patterning genes and demonstrate that ventral proteoglycan sulfation serves as a positional cue for sea urchin skeletal patterning.


Sujet(s)
Plan d'organisation du corps/génétique , Protéoglycanes/métabolisme , Echinoidea/embryologie , Echinoidea/génétique , Analyse de séquence d'ARN/méthodes , Sulfates/métabolisme , Animaux , Plan d'organisation du corps/effets des médicaments et des substances chimiques , Transporteurs de cations/métabolisme , Différenciation cellulaire/effets des médicaments et des substances chimiques , Ectoderme/effets des médicaments et des substances chimiques , Ectoderme/enzymologie , Embryon non mammalien/effets des médicaments et des substances chimiques , Embryon non mammalien/métabolisme , Régulation de l'expression des gènes au cours du développement/effets des médicaments et des substances chimiques , Mésoderme/cytologie , Modèles biologiques , Nickel/toxicité , Echinoidea/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Facteur de croissance endothéliale vasculaire de type A/métabolisme , p38 Mitogen-Activated Protein Kinases/antagonistes et inhibiteurs , p38 Mitogen-Activated Protein Kinases/métabolisme
4.
Mol Vis ; 18: 1339-53, 2012.
Article de Anglais | MEDLINE | ID: mdl-22690112

RÉSUMÉ

PURPOSE: Adrenomedullin (ADM) is a small, secreted peptide often associated with vasodilation. However, ADM can also function as a neurotransmitter/neuromodulator, and studies suggest ADM is upregulated in the eye in several ocular diseases. However, no studies to date have described an ADM signaling pathway in the retina. METHODS: PCR, immunocytochemistry, nitric oxide imaging, western blots, and a nitrite assay were used to determine the localization of the components of the ADM signaling pathway in the mouse retina. RESULTS: We used reverse-transcriptase polymerase chain reaction to show that ADM and its primary receptor, calcitonin-receptor-like receptor, along with its associated receptor activity modifying proteins 2 and 3 are expressed in the retina. Using immunocytochemistry, we detected ADM staining throughout the retina in the photoreceptor outer segments, the outer nuclear layer, Müller and amacrine cell somata in the inner nuclear layer, and some somata in the ganglion cell layer. We found that calcitonin-receptor-like receptor and receptor activity modifying protein 2 had localization patterns similar to ADM, especially in somata in the inner nuclear and ganglion cell layers. Finally, we showed that the ADM receptor was functional in the retina. Stimulation of isolated retinas with ADM increased cyclic adenosine monophosphate- and cyclic guanosine monophosphate-like immunoreactivity, as well as nitric oxide production. CONCLUSIONS: These results are the first to show that ADM and functional ADM receptors are present in the retina. Since ADM is increased in eyes with ocular pathologies such as diabetic retinopathy, glaucoma, retinitis pigmentosa, and uveitis, the ADM signaling pathway may provide a new target for ameliorating these retinal pathologies.


Sujet(s)
Adrénomédulline/génétique , Protéines de l'oeil/génétique , Cellules photoréceptrices de vertébré/métabolisme , Cellules ganglionnaires rétiniennes/métabolisme , Transduction du signal/génétique , Adrénomédulline/métabolisme , Animaux , Technique de Western , Protéine apparentée au récepteur de la calcitonine/génétique , Protéine apparentée au récepteur de la calcitonine/métabolisme , AMP cyclique/métabolisme , GMP cyclique/métabolisme , Protéines de l'oeil/métabolisme , Immunohistochimie , Souris , Monoxyde d'azote , Cellules photoréceptrices de vertébré/cytologie , Protéine-2 modifiant l'activité des récepteurs/génétique , Protéine-2 modifiant l'activité des récepteurs/métabolisme , Protéine-3 modifiant l'activité des récepteurs/génétique , Protéine-3 modifiant l'activité des récepteurs/métabolisme , Cellules ganglionnaires rétiniennes/cytologie , RT-PCR
5.
Development ; 138(2): 327-38, 2011 Jan.
Article de Anglais | MEDLINE | ID: mdl-21177345

RÉSUMÉ

The Bcl-2 family has been shown to regulate mitochondrial dynamics during cell death in mammals and C. elegans, but evidence for this in Drosophila has been elusive. Here, we investigate the regulation of mitochondrial dynamics during germline cell death in the Drosophila melanogaster ovary. We find that mitochondria undergo a series of events during the progression of cell death, with remodeling, cluster formation and uptake of clusters by somatic follicle cells. These mitochondrial dynamics are dependent on caspases, the Bcl-2 family, the mitochondrial fission and fusion machinery, and the autophagy machinery. Furthermore, Bcl-2 family mutants show a striking defect in cell death in the ovary. These data indicate that a mitochondrial pathway is a major mechanism for activation of cell death in Drosophila oogenesis.


Sujet(s)
Protéines de Drosophila/métabolisme , Drosophila melanogaster/cytologie , Drosophila melanogaster/métabolisme , Ovaire/cytologie , Ovaire/métabolisme , Protéines proto-oncogènes c-bcl-2/métabolisme , Animaux , Animal génétiquement modifié , Apoptose/génétique , Apoptose/physiologie , Autophagie/génétique , Autophagie/physiologie , Caspases/métabolisme , Protéines de Drosophila/génétique , Drosophila melanogaster/génétique , Drosophila melanogaster/croissance et développement , Femelle , Gènes d'insecte , Gènes bcl-2 , Mitochondries/métabolisme , Mitochondries/ultrastructure , Mutation , Ovogenèse/génétique , Ovogenèse/physiologie , Ovaire/croissance et développement , Protéines proto-oncogènes c-bcl-2/génétique
6.
Vis Neurosci ; 26(3): 275-86, 2009.
Article de Anglais | MEDLINE | ID: mdl-19602301

RÉSUMÉ

Nitric oxide (NO) is a gaseous neuromodulator that has physiological functions in every cell type in the retina. Evidence indicates that NO often plays a role in the processing of visual information in the retina through the second messenger cyclic guanosine monophosphate (cGMP). Despite numerous structural and functional studies of this signaling pathway in the retina, none have examined many of the elements of this pathway within a single study in a single species. In this study, the NO/cGMP pathway was localized to specific regions and cell types within the inner and outer retina. We have immunocytochemically localized nitric oxide synthase, the enzyme that produces NO, in photoreceptor ellipsoids, four distinct classes of amacrine cells, Müller and bipolar cells, somata in the ganglion cell layer, as well as in processes within both plexiform layers. Additionally, we localized NO production in specific cell types using the NO-sensitive dye diaminofluorescein. cGMP immunocytochemistry was used to functionally localize soluble guanylate cyclase that was activated by an NO donor in select amacrine and bipolar cell classes. Analysis of cGMP and its downstream target, cGMP-dependent protein kinase II (PKGII), showed colocalization within processes in the outer retina as well as in somata in the inner retina. The results of this study showed that the NO/cGMP signaling pathway was functional and its components were widely distributed throughout specific cell types in the outer and inner salamander retina.


Sujet(s)
GMP cyclique/métabolisme , Monoxyde d'azote/métabolisme , Rétine/métabolisme , Urodela/métabolisme , Cellules amacrines/métabolisme , Animaux , Technique de Western , GMP cyclique/biosynthèse , Cyclic GMP-Dependent Protein Kinases/métabolisme , Activation enzymatique , Guanylate cyclase/métabolisme , Immunohistochimie/méthodes , Larve , Donneur d'oxyde nitrique/pharmacologie , Nitric oxide synthase type I/métabolisme , Rétine/cytologie , Cellules bipolaires rétiniennes/métabolisme , Transduction du signal/physiologie , Coloration et marquage , Distribution tissulaire , Urodela/croissance et développement
7.
Vision Res ; 45(28): 3469-86, 2005 Dec.
Article de Anglais | MEDLINE | ID: mdl-16171845

RÉSUMÉ

Nitric oxide (NO) is the most widespread signaling molecule found in the retina in that it can be made by every retinal cell type. NO is able to influence a wide variety of synaptic mechanisms ranging from increasing or decreasing neurotransmitter release to the modulation of gap junction conductivity. Although biochemical methods can analyze overall levels of NO, such methods cannot indicate the specific cell types involved. In the last few years, fluorescent imaging methods utilizing diaminofluorescein have allowed the real-time visualization of neurochemically or light stimulated NO-induced fluorescence (NO-IF) in specific retinal cells. Recent experiments have shown that this NO-IF can be stabilized using paraformaldehyde fixation. This aldehyde stabilization has allowed the imaging of NO production in the dark and in response to light, as well as the neurochemical modulation of light stimulated NO production. The results of these studies indicate that NO is not always freely diffusible and that NO is largely retained in many cells which make it. The NO production in retina is highly damped in that in the absence of stimulation, the endogenous levels of NO production are extremely low. Finally, different neurochemical or light stimulation protocols activate NO production in specific cells and subcellular compartments. Therefore, although the NO signaling is widespread in retina, it is very selectively activated and has different functions in specific retinal cell types. The use of NO imaging will continue to play a critical role in future studies of the function of NO in retina and other neural systems.


Sujet(s)
Monoxyde d'azote/métabolisme , Rétine/métabolisme , Animaux , GMP cyclique/métabolisme , Immunohistochimie , Microscopie électronique , Rétine/ultrastructure , Transduction du signal/physiologie
8.
Nano Lett ; 5(4): 603-7, 2005 Apr.
Article de Anglais | MEDLINE | ID: mdl-15826094

RÉSUMÉ

Quantum dots (QDs) could serve as fluorescent scaffolds for effecting specific physiological and pharmacological responses in cells. Here, we conjugate the peptide ligand betaNGF to QD surfaces, and confirm surface modification and single QD nanostructure using AFM. We show that betaNGF-QDs retain bioactivity, activate TrkA receptors, and initiate neuronal differentiation in PC12 cells. Receptor-evoked activity of QD-immobilized ligands has wide-ranging implications for the development of molecular tools and therapeutics targeted at understanding and regulating cell function.


Sujet(s)
Facteur de croissance nerveuse/pharmacologie , Neurites/effets des médicaments et des substances chimiques , Neurones/cytologie , Peptides/composition chimique , Boîtes quantiques , Récepteur trkA/agonistes , Animaux , Différenciation cellulaire , Fluorescence , Ligands , Microscopie à force atomique , Facteur de croissance nerveuse/composition chimique , Cellules PC12 , Rats , Cellules réceptrices sensorielles/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques
9.
Vis Neurosci ; 20(2): 165-76, 2003.
Article de Anglais | MEDLINE | ID: mdl-12916738

RÉSUMÉ

Acetylcholine is one of the primary excitatory neurotransmitters/neuromodulators in the retina, but little is known about the downstream signaling pathways it can activate. The present study immunocytochemically examines the potential sources of acetylcholine and the location of the nicotinic cholinergic receptors in the turtle retina. It also examines how activation of these receptors can influence the nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) signal-transduction pathways. Photoreceptors, amacrine cells, and potentially ganglion cells contain choline acetyltransferase-like immunoreactivity (LI). Nicotinic acetylcholine receptors are immunocytochemically localized on photoreceptors, horizontal, bipolar, and ganglion cells. Nitric oxide imaging indicates that stimulation with nicotine increases NO production primarily in photoreceptors, horizontal, Muller, bipolar, and ganglion cells. In turn, very select populations of amacrine cells respond to this NO with increased levels of cGMP-LI. Selective inhibitors reveal that nitric oxide synthase is involved in most, but not all, of these increases in cGMP-LI. These results show that acetylcholine can activate the NO/cGMP signal-transduction pathways in both the inner and outer retina. This indicates that both of the major excitatory retinal transmitters, glutamate and acetylcholine, can stimulate NO production that increases levels of cGMP-LI in overlapping populations of retinal cells.


Sujet(s)
GMP cyclique/métabolisme , Nicotine/pharmacologie , Monoxyde d'azote/métabolisme , Rétine/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Animaux , Choline O-acetyltransferase/métabolisme , Test ELISA , Fluorescéine , Immunohistochimie , Techniques in vitro , Indicateurs et réactifs , Nitric oxide synthase/métabolisme , Récepteurs nicotiniques/métabolisme , Rétine/effets des médicaments et des substances chimiques , Tortues
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...